{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:19:40Z","timestamp":1791159580585,"version":"4.1.0"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>Background. Developmental coordination disorder (DCD) affects \u223c5% of school-aged children. In addition to the core deficits in motor function, this condition is associated commonly with difficulties in learning, behavior, and psychosocial adjustment that persist into adulthood. Mounting evidence suggests that a relative lack of certain polyunsaturated fatty acids may contribute to related neurodevelopmental and psychiatric disorders such as dyslexia and attention-deficit\/hyperactivity disorder. Given the current lack of effective, evidence-based treatment options for DCD, the use of fatty acid supplements merits investigation.<\/jats:p>\n               <jats:p>Methods. A randomized, controlled trial of dietary supplementation with \u03c9-3 and \u03c9-6 fatty acids, compared with placebo, was conducted with 117 children with DCD (5\u201312 years of age). Treatment for 3 months in parallel groups was followed by a 1-way crossover from placebo to active treatment for an additional 3 months.<\/jats:p>\n               <jats:p>Results. No effect of treatment on motor skills was apparent, but significant improvements for active treatment versus placebo were found in reading, spelling, and behavior over 3 months of treatment in parallel groups. After the crossover, similar changes were seen in the placebo-active group, whereas children continuing with active treatment maintained or improved their progress.<\/jats:p>\n               <jats:p>Conclusions. Fatty acid supplementation may offer a safe efficacious treatment option for educational and behavioral problems among children with DCD. Additional work is needed to investigate whether our inability to detect any improvement in motor skills reflects the measures used and to assess the durability of treatment effects on behavior and academic progress.<\/jats:p>","DOI":"10.1542\/peds.2004-2164","type":"journal-article","created":{"date-parts":[[2005,5,2]],"date-time":"2005-05-02T19:38:07Z","timestamp":1115062687000},"page":"1360-1366","source":"Crossref","is-referenced-by-count":338,"title":["The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder"],"prefix":"10.1542","volume":"115","author":[{"given":"Alexandra J.","family":"Richardson","sequence":"first","affiliation":[{"name":"University Laboratory of Physiology, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry"},{"name":"Departments of Social Policy and Social Work, University of Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"key":"2021120819281702400_R1","doi-asserted-by":"crossref","unstructured":"Simopoulos AP. The importance of the ratio of \u03c9-6\/\u03c9-3 essential fatty acids. Biomed Pharmacother.\u20082002;56:365\u2013379","DOI":"10.1016\/S0753-3322(02)00253-6"},{"key":"2021120819281702400_R2","doi-asserted-by":"crossref","unstructured":"Haag M. Essential fatty acids and the brain. Can J Psychiatry.\u20082003;48:195\u2013203","DOI":"10.1177\/070674370304800308"},{"key":"2021120819281702400_R3","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit\/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids.\u20082000;63:1\u20139","DOI":"10.1054\/plef.2000.0184"},{"key":"2021120819281702400_R4","doi-asserted-by":"crossref","unstructured":"Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids.\u20082004;70:383\u2013390","DOI":"10.1016\/j.plefa.2003.12.020"},{"key":"2021120819281702400_R5","doi-asserted-by":"crossref","unstructured":"Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry.\u20082002;26:233\u2013239","DOI":"10.1016\/S0278-5846(01)00254-8"},{"key":"2021120819281702400_R6","doi-asserted-by":"crossref","unstructured":"Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviours. Lipids.\u20082003;38:1007\u20131021","DOI":"10.1007\/s11745-006-1155-0"},{"key":"2021120819281702400_R7","doi-asserted-by":"crossref","unstructured":"Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit\/hyperactivity disorder. J Pediatr.\u20082001;139:189\u2013196","DOI":"10.1067\/mpd.2001.116050"},{"key":"2021120819281702400_R8","doi-asserted-by":"crossref","unstructured":"Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit\/hyperactivity disorder: a placebo-controlled double-blind study. Eur J Clin Nutr.\u20082004;58:467\u2013473","DOI":"10.1038\/sj.ejcn.1601830"},{"key":"2021120819281702400_R9","doi-asserted-by":"crossref","unstructured":"Stordy BJ. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr.\u20082000;71:323S\u2013326S","DOI":"10.1093\/ajcn\/71.1.323S"},{"key":"2021120819281702400_R10","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000"},{"key":"2021120819281702400_R11","doi-asserted-by":"crossref","unstructured":"Kadesjo B, Gillberg C. Developmental coordination disorder in Swedish 7-year-old children. J Am Acad Child Adolesc Psychiatry.\u20081999;38:820\u2013828","DOI":"10.1097\/00004583-199907000-00011"},{"key":"2021120819281702400_R12","doi-asserted-by":"crossref","unstructured":"Dewey D, Kaplan BJ, Crawford SG, Wilson BN. Developmental coordination disorder: associated problems in attention, learning, and psychosocial adjustment. Hum Mov Sci.\u20082002;21:905\u2013918","DOI":"10.1016\/S0167-9457(02)00163-X"},{"key":"2021120819281702400_R13","doi-asserted-by":"crossref","unstructured":"Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry.\u20082000;39:1424\u20131431","DOI":"10.1097\/00004583-200011000-00017"},{"key":"2021120819281702400_R14","doi-asserted-by":"crossref","unstructured":"Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development. Lipids.\u20082001;36:885\u2013895","DOI":"10.1007\/s11745-001-0798-1"},{"key":"2021120819281702400_R15","doi-asserted-by":"crossref","unstructured":"Moriguchi T, Greiner RS, Salem N Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem.\u20082000;75:2563\u20132573","DOI":"10.1046\/j.1471-4159.2000.0752563.x"},{"key":"2021120819281702400_R16","doi-asserted-by":"crossref","unstructured":"Bourre JM, Durand G, Pascal G, Youyou A. Brain cell and tissue recovery in rats made deficient in n\u22123 fatty acids by alteration of dietary fat. J Nutr.\u20081989;119:15\u201322","DOI":"10.1093\/jn\/119.1.15"},{"key":"2021120819281702400_R17","unstructured":"Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. London, United Kingdom: The Psychological Corp, Harcourt Brace; 1992"},{"key":"2021120819281702400_R18","unstructured":"Henderson SE, Sugden D. Movement Assessment Battery for Children. New York, NY: The Psychological Corp, Harcourt Brace; 1992"},{"key":"2021120819281702400_R19","unstructured":"Wechsler D. Wechsler Objective Reading Dimensions (WORD). London, United Kingdom: The Psychological Corp, Harcourt Brace; 1993"},{"key":"2021120819281702400_R20","doi-asserted-by":"crossref","unstructured":"Conners CK. Conners' Parent Rating Scales-Revised. New York, NY: Multi-Health Systems; 1997","DOI":"10.1037\/t81067-000"},{"key":"2021120819281702400_R21","unstructured":"Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ.\u20082001;165:1475\u20131488"},{"key":"2021120819281702400_R22","doi-asserted-by":"crossref","unstructured":"Hellgren L, Gillberg C, Gillberg IC, Enerskog I. Children with deficits in attention, motor control and perception (DAMP) almost grown up: general health at 16 years. Dev Med Child Neurol.\u20081993;35:881\u2013892","DOI":"10.1111\/j.1469-8749.1993.tb11565.x"},{"key":"2021120819281702400_R23","doi-asserted-by":"crossref","unstructured":"Hellgren L, Gillberg IC, Bagenholm A, Gillberg C. Children with deficits in attention, motor control and perception (DAMP) almost grown up: psychiatric and personality disorders at age 16 years. J Child Psychol Psychiatry.\u20081994;35:1255\u20131271","DOI":"10.1111\/j.1469-7610.1994.tb01233.x"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1360\/1028933\/zpe00505001360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1360\/1028933\/zpe00505001360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:54:59Z","timestamp":1638996899000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/5\/1360\/67589\/The-Oxford-Durham-Study-A-Randomized-Controlled"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2164","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}